WO2004094651A3 - Novel human polypeptides encoded by polynucleotides - Google Patents
Novel human polypeptides encoded by polynucleotides Download PDFInfo
- Publication number
- WO2004094651A3 WO2004094651A3 PCT/US2004/012049 US2004012049W WO2004094651A3 WO 2004094651 A3 WO2004094651 A3 WO 2004094651A3 US 2004012049 W US2004012049 W US 2004012049W WO 2004094651 A3 WO2004094651 A3 WO 2004094651A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polynucleotides
- polypeptides encoded
- novel human
- human polypeptides
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46370003P | 2003-04-18 | 2003-04-18 | |
US60/463,700 | 2003-04-18 | ||
US46720303P | 2003-05-02 | 2003-05-02 | |
US60/467,203 | 2003-05-02 | ||
US47660903P | 2003-06-09 | 2003-06-09 | |
US47663203P | 2003-06-09 | 2003-06-09 | |
US60/476,609 | 2003-06-09 | ||
US60/476,632 | 2003-06-09 | ||
US48532503P | 2003-07-08 | 2003-07-08 | |
US48535903P | 2003-07-08 | 2003-07-08 | |
US60/485,325 | 2003-07-08 | ||
US60/485,359 | 2003-07-08 | ||
US48696003P | 2003-07-15 | 2003-07-15 | |
US60/486,960 | 2003-07-15 | ||
US49333203P | 2003-08-08 | 2003-08-08 | |
US49337003P | 2003-08-08 | 2003-08-08 | |
US60/493,332 | 2003-08-08 | ||
US60/493,370 | 2003-08-08 | ||
US50505903P | 2003-09-08 | 2003-09-08 | |
US60/505,059 | 2003-09-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004094651A2 WO2004094651A2 (en) | 2004-11-04 |
WO2004094651A3 true WO2004094651A3 (en) | 2009-03-26 |
Family
ID=33314651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/012049 WO2004094651A2 (en) | 2003-04-18 | 2004-04-19 | Novel human polypeptides encoded by polynucleotides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004094651A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2649250A1 (en) | 2006-04-11 | 2007-10-25 | Eisai R & D Management Co., Ltd. | Dopaminergic neuron progenitor cell marker 187a5 |
US20100196351A1 (en) * | 2007-02-15 | 2010-08-05 | Geneswitch Innovations Llc | Secreted pate-like proteins |
WO2008141230A1 (en) * | 2007-05-09 | 2008-11-20 | Lawrence Livermore National Security, Llc | Methods and systems for monitoring production of a target protein in a nanolipoprotein particle |
US9688718B2 (en) | 2008-01-11 | 2017-06-27 | Lawrence Livermore National Security, Llc | Nanolipoprotein particles comprising hydrogenases and related products, methods and systems |
US9303273B2 (en) | 2008-05-09 | 2016-04-05 | Lawrence Livermore National Security, Llc | Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems |
WO2009143280A2 (en) | 2008-05-22 | 2009-11-26 | Lawrence Livermore National Security, Llc | Nanolipoprotein particles and related compositions, methods and systems |
US9453840B2 (en) | 2011-07-27 | 2016-09-27 | Kyoto University | Markers for dopaminergic neuron progenitor cells |
US9644038B2 (en) | 2011-12-21 | 2017-05-09 | The Regents Of The University Of California | Apolipoprotein nanodiscs with telodendrimer |
WO2016049061A1 (en) | 2014-09-22 | 2016-03-31 | Lawrence Livermore National Security, Llc | Electrochemical flow-cell for hydrogen production and nicotinamide co-factor dependent target reduction, and related methods and systems |
US11279749B2 (en) | 2015-09-11 | 2022-03-22 | Lawrence Livermore National Security, Llc | Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation |
US11207422B2 (en) | 2017-05-02 | 2021-12-28 | Lawrence Livermore National Security, Llc | MOMP telonanoparticles, and related compositions, methods and systems |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001075067A2 (en) * | 2000-03-31 | 2001-10-11 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
-
2004
- 2004-04-19 WO PCT/US2004/012049 patent/WO2004094651A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001075067A2 (en) * | 2000-03-31 | 2001-10-11 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
US20050196754A1 (en) * | 2000-03-31 | 2005-09-08 | Drmanac Radoje T. | Novel nucleic acids and polypeptides |
Also Published As
Publication number | Publication date |
---|---|
WO2004094651A2 (en) | 2004-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004020595A8 (en) | Novel human polypeptides encoded by polynucleotides | |
WO2004035732A3 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
WO2004093804A3 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
PL1767546T3 (en) | Angiogenesis-inhibiting chimeric protein and the use | |
WO2008054561A3 (en) | Proteins, nucleic acids encoding the same and associated methods of use | |
WO2002055705A3 (en) | Proteins and nucleic acids encoding same | |
WO2002050277A3 (en) | Protein and nucleic acids encoding same | |
WO2007060213A3 (en) | Erythropoietin polypeptides and uses thereof | |
WO2004094651A3 (en) | Novel human polypeptides encoded by polynucleotides | |
WO2007087053A3 (en) | Bmp-7 variant compositions, methods and uses | |
WO2002068649A3 (en) | Proteins and nucleic acids encoding same | |
WO2002081518A3 (en) | Proteins, polynucleotides encoding them and methods of using the same | |
WO2001090155A3 (en) | Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses | |
WO2008060776A3 (en) | Atap peptides, nucleic acids encoding the same and associated methods of use | |
WO2004015060A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2005085280A3 (en) | HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE | |
WO2001081578A3 (en) | Novel proteins and nucleic acids encoding same | |
WO2002068652A3 (en) | Nov-x proteins and nucleic acids encoding same | |
WO2002016599A3 (en) | Proteins and nucleic acids encoding same | |
WO2002055704A3 (en) | Proteins, polynucleotides encoding them and methods of using the same | |
WO2002081510A3 (en) | Proteins, polynucleotides encoding them and methods of using the same | |
WO2004020591A3 (en) | Methods of use for novel human polypeptides encoded by polynucleotides | |
WO2002079398A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2002099116A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2004038003A3 (en) | Human polypeptides encoded by polynucleotides and methods of their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |